<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="foods-10-00095-t007" orientation="portrait" position="float">
 <object-id pub-id-type="pii">foods-10-00095-t007_Table 7</object-id>
 <label>Table 7</label>
 <caption>
  <p>Bioactivity potency and testing methods of major bioactive molecules isolated from 
   <italic>G. frondosa</italic>.
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bioactivity</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bioactive Components</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Name of Fraction</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Testing Method</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Potency of Bioactivity</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref. </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="9" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-tumor</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D-fraction</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo counting of the number of tumor foci metastasized using stereoscope wide field microscopy</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 mg/kg/day for 17 days against MM46 liver carcinoma, 91.3% inhibition ratio</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B80-foods-10-00095" ref-type="bibr">80</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GFP-A</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro testing of cancer cell viability using MTT assay</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">150 μg/mL at 48 h, 50% inhibition (IC
     <sub>50</sub>) of human colon cancer cells
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B65-foods-10-00095" ref-type="bibr">65</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MD-fraction</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo assessing of inhibition rate by measuring tumor weight</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1 mg/kg at 10 times after transplanting MM46 carcinoma, 94.3% inhibition ratio</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B22-foods-10-00095" ref-type="bibr">22</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MZ-fraction</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo assessing of tumor inhibition by measuring tumor weight</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 mg/kg/day against MM46 carcinoma, 70.3% inhibition ratio</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B25-foods-10-00095" ref-type="bibr">25</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GFP-A</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo assessing of tumor inhibition rate in mice inoculated with S180 sarcoma cells</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral administration of 50, 100 and 200 mg/kg for 15 days, tumor inhibitory rates were 17.1%, 28.3% and 52.2% respectively</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B55-foods-10-00095" ref-type="bibr">55</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LMw-GFP</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo assessing of tumor inhibition rate in mice inoculated with H22 hepatoma cells</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral administration of 200 mg/kg for 15 days, tumor inhibitory ratio was 40.1%</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B51-foods-10-00095" ref-type="bibr">51</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GFAP</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo assessing of tumor inhibition rate in H22 hepatoma cell-bearing mice </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intragastric administration of 100 and 200 mg/kg for 15 days, tumor inhibitory rate was 16.36% and 36.72% respectively</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B56-foods-10-00095" ref-type="bibr">56</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycoprotein</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GFG-3a</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro testing of cancer cell viability using MTT assay</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20 μg/mL against sarcoma 180 cells, 92% inhibition ratio; 60 μg/mL against BEL 7402 cells, 95% inhibition ratio</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B32-foods-10-00095" ref-type="bibr">32</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Water soluble extract</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro counting under a phase-contrast microscope</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10% 
     <italic>w/v</italic> Maitake extract against TMK-1 gastric cancer cell lines for 3 days, 90% inhibition ratio
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B81-foods-10-00095" ref-type="bibr">81</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Immuno-modulatory</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D-fraction</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro evaluation of cytokine production using ELISA</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.0 mg/kg/day, 3000 pg/mL IL-12 production</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B82-foods-10-00095" ref-type="bibr">82</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GRN</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro evaluation of cytokine production and activity of macrophages using ELISA and MTT assay</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100 μg/mL, 11.050 ng/mL IL-6 production and 14.458 ng/mL TNF-α production by RAW264.7 cells</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B24-foods-10-00095" ref-type="bibr">24</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GP11</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro evaluation of cytokine production and activity of macrophages using ELISA and MTT assay</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1000 μg/mL, 81.84 pg/mL TNF-α, 229.07 pg/mL IL-1β level</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B64-foods-10-00095" ref-type="bibr">64</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MZ-fraction</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro determination of TNF-α or IL-12 by ELISA</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">500 μg/mL, around 85 pg/mL IL-12 and 50 ng/mL TNF-α by J774.1 macrophage</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B25-foods-10-00095" ref-type="bibr">25</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GFP</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro macrophage proliferation assessment using MTT assay; concentration of cytokine and chemokine measured by multiplex magnetic bead panel kit</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40 μg/mL, 150% cell viability for 36 h</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B68-foods-10-00095" ref-type="bibr">68</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fr. I and II</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro human blood cytokine concentrations determined by ELISA</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1 mg/mL Fr. II, around 3700 pg/mL TNF-α, 360 pg/mL IFN-γ and 4400 pg/mL IL-6</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B83-foods-10-00095" ref-type="bibr">83</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Antiviral/
     <break/>antibacterial
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D-fraction</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo determination of the survival rate of 
     <italic>Listeria monocytogenes</italic> by estimating colony-forming units (CFUs);
     <break/>In vitro HBV DNA and viral antigen analysis using quantitative real-time polymerase chain reaction and end-point titration in radioimmunoassays, respectively
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 mg/kg/d, survived rate of 
     <italic>L. monocytogenes</italic> = 67%;
     <break/>IC
     <sub>50</sub> for HBV DNA in cells = 0.59 mg/mL; IC
     <sub>50</sub> for HBV polymerase = 1.38 mg/mL;
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B84-foods-10-00095" ref-type="bibr">84</xref>,
     <xref rid="B85-foods-10-00095" ref-type="bibr">85</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GFP1</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro EV71-infected cell inhibition rate determination using CCK-8 assay</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">250 μg/mL extract, inhibition rate = 20% after 10 h</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B27-foods-10-00095" ref-type="bibr">27</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GFAHP</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro HSV-1 virus quantity analysis using plaque reduction assay;
     <break/>In vivo HSV-1 virus measurement using plaque assay
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC
     <sub>50</sub> for HSV-1 replication = 4.1 μg/mL;
     <break/>150 μg/mL, mean virus titer 12.7% compared to control after 24 h
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B35-foods-10-00095" ref-type="bibr">35</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Antidiabetic</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F2/F3</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo fasting serum glucose (FSG) level measurement using glucose oxidase method in diabetes rat model</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intake 100 mg/kg/d F2 or 50 mg/kg/d F3 for two weeks, inhibits a rise in FSG level</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B63-foods-10-00095" ref-type="bibr">63</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MT-α-glucan</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo glucose oxidase method using reflective glucometer on KK-Ay mice </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intake 150 mg/kg/d for two weeks, decrease around 23% FSG</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B26-foods-10-00095" ref-type="bibr">26</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"> </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n-hexane extract</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GF-H</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro α-amylase inhibition assay and α-glucosidase inhibition assay;
     <break/>In vivo glucose level measurement by the glucose oxidase method in high-fat-diet and streptozotocin (HFD + STZ)-induced hyperglycemic mice
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC
     <sub>50</sub> of α-amylase and α-glucosidase: 3.75 mg/mL and 0.04 mg/mL respectively;
     <break/>Intake 600 mg/kg, blood glucose level decrease 28%
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B86-foods-10-00095" ref-type="bibr">86</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycoprotein</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SX-fraction</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo FBG measurement on type 2 diabetic patients</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intake 2–4 weeks, 30–63% decline in FBG</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B87-foods-10-00095" ref-type="bibr">87</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Small molecules</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ergosterol peroxide</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro assessment of antidiabetic activity in palmitate-induced murine C2C12 skeletal muscle cells by measuring glucose uptake</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">At 5 μM, the increase in the glucose absorption rate was as good as that of the insulin-treated cells</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B75-foods-10-00095" ref-type="bibr">75</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Lipid metabolism/
     <break/>hypertension
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dry Maitake powder</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro testing using a commercial kit (cholesterol E-Test, Phospholipid B-Test Triglyceride E-Test)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liver weight 0.68 times lower than control; Triglyceride, total cholesterol and free cholesterol reduced by 0.46 times, 0.54 times and 0.65 times in liver with diet containing 20% maitake for 11 d</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B88-foods-10-00095" ref-type="bibr">88</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dry Maitake fiber</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro total cholesterol, HDL cholesterol and triglyceride concentrations in the serum, determined enzymatically by commercially available reagent kits</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serum total cholesterol concentration reduced by 11% than control by 50 g/kg maitake for 4 weeks</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B89-foods-10-00095" ref-type="bibr">89</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Water extract</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo systolic blood pressure (SBP) level measurement using tail plethysmography in aging female rats</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intake 350 mg/kg for 120 d, significantly lower SBP level</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B90-foods-10-00095" ref-type="bibr">90</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Antioxidant</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IZPS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro access of hydroxyl radical, DPPH radical, superoxide radical and hydrogen peroxide scavenging ability, reducing power and Fe
     <sup>2+</sup>chelating activity by chemical methods
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EC
     <sub>50</sub> scavenging •OH, DPPH• and O
     <sup>2−</sup> are 204 mg/L; 211 mg/L and 525 mg/L; At 1000 mg/L, H
     <sub>2</sub>O
     <sub>2</sub> scavenging rate 95%; reducing power (abs at 700 nm) 0.38; Fe
     <sup>2+</sup>chelating activity 51%
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B91-foods-10-00095" ref-type="bibr">91</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G-2/G-3</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro assessment of the superoxide scavenging activity by chemical assay;
     <break/>In vitro assessment of free radical scavenging activity after UV irradiation in HDF cells
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">At 0.2% w/v, inhibit 90% (G2) and 75% (G3) O
     <sup>2−</sup>; decreased free radicals (formed after UV irradiation) by 20% for both G2 and G3
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B92-foods-10-00095" ref-type="bibr">92</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GFP-1, GFP-2/GFP-3</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro assessment of of hydroxyl radical, DPPH radical and superoxide radical scavenging ability and Fe
     <sup>2+</sup>chelating activity by chemical methods
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">At 3.0 mg/mL, the scavenging rate of DPPH•, •OH, O
     <sup>2−</sup>•: 49, 48 and 45% (GFP-1); 78, 53 &amp; 53% (GFP-2) &amp; 66, 93 &amp; 83% (GFP-3); At 5 mg/L, Fe
     <sup>2+</sup>chelating rate: 91% (GFP-1); 98% (GFP-2) and 80% (GFP-3)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B93-foods-10-00095" ref-type="bibr">93</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Se-GFP-22</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro assessment of DPPH radical scavenging ability</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">At 1000 μg/mL, 46% scavenging rate</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B67-foods-10-00095" ref-type="bibr">67</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GFHT-4</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro assessment of DPPH radical scavenging ability, Fe
     <sup>2+</sup>chelating activity, reducing power and inhibition of linoleic acid autoxidation power by chemical methods
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">At 2.5 mg/mL, inhibits 90% DPPH•, chelate 80% Fe
     <sup>2+</sup>, reducing power close to 1.5 mg ascorbic acid/mL; At 0.5 mg/mL, inhibition of linoleic acid autoxidation power equivalent to BHA (0.5 mg/mL)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B94-foods-10-00095" ref-type="bibr">94</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Small molecule</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ergosterol, ergostra-4,6,8(14), 22-tetraen-3-one, &amp; 1-oleoyl-2-linoleoyl-3-palmitoylglycerol</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro assessment of antioxidants by liposome oxidation model</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">At 100 μg/mL, 79, 48% and 42% inhibition rate, respectively</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B73-foods-10-00095" ref-type="bibr">73</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Microbiota regulation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GFP</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo measurement of gut microbiota in high-fat-diet-fed rats by high-throughput sequencing</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">For GFP (400 mg/kg day)-treated group, significant increase in the relative abundance of 
     <italic>Helicobater</italic>, 
     <italic>Intestinimonas</italic>, 
     <italic>Barnesiella</italic>, 
     <italic>Parasutterella</italic>, 
     <italic>Ruminococcus</italic> and 
     <italic>Flavonifracter</italic>, and decrease in Clostridium-XVIII, 
     <italic>Butyricicoccus</italic> and 
     <italic>Turicibacter</italic>. Similar gut microbiota composition to that of the normal group.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B95-foods-10-00095" ref-type="bibr">95</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GFP-N</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo determination of intestinal microflora in a diabetes rat model using single-molecule real-time sequencing</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">For GFP-N-fed group (75 and 150 mg/kg day), significant increase of the relative abundances of 
     <italic>Porphyromonas gingivalis</italic>, 
     <italic>Akkermansia muciniphila</italic>, 
     <italic>Lactobacillus acidophilus</italic>, 
     <italic>Tannerella forsythia</italic>, 
     <italic>Bacteroides acidifaciens</italic> and 
     <italic>Roseburia intestinalis</italic>. Similar gut microbiota composition to that of the normal group.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B31-foods-10-00095" ref-type="bibr">31</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GFP</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo access of gut microbiota in high-fat diet-fed and streptozotocin-treated mice by high throughput sequencing.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">For GFP-treated (900 mg/kg day) group, significant increase in the relative abundance of 
     <italic>Alistipes</italic> and 
     <italic>Bacteroides</italic>, and decrease in 
     <italic>Enterococcus</italic>.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B96-foods-10-00095" ref-type="bibr">96</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GFP</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo evaluation of gut microbiota in high-fat-diet-fed rats by high-throughput next-generation 16S rRNA gene sequencing.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">For GFP-treated (150 mg/kg day) group, significant increase in the relative abundance of 
     <italic>Allobaculum</italic>, 
     <italic>Bacteroides</italic>, 
     <italic>Bifidobacterium</italic> and other cecal microbiota compared with the HFD-fed group.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B30-foods-10-00095" ref-type="bibr">30</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GFWE</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo access of gut microbiota in high-sucrose- and high-fat-diet-fed rats by real-time sequencing.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">For GFWE-treated (150 mg/kg day) group, increase in the relative abundance of caecal bacteria 
     <italic>Oscillibacter</italic> and 
     <italic>Barnesiella</italic>.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B97-foods-10-00095" ref-type="bibr">97</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Small molecule</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GF95 (mainly 4-hydroxyhippuric acid, flavone derivatives, luteolin, luteolin 6,7-dimethoxy &amp; jaceosidin or 5,7,4-trihydroxy-3)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo access of gut microbiota in high-fat-diet-fed rats by real-time sequencing</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">For GF95 (150 mg/kg day)-fed group, a higher relative abundance of 
     <italic>Intestinimonas</italic> and 
     <italic>Butyricimonas</italic> than that fed with HFD only.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B98-foods-10-00095" ref-type="bibr">98</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
